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Fish oil concentrate delays sensitivity to thermal nociception in
mice
Jyothi M. Veigasa, Paul J. Williamsa, Ganesh Haladea, Mizanur M. Rahmana, Toshiyuki
Yonedaa,b, and Gabriel Fernandesa,*
aDepartment of Medicine, Division of Clinical Immunology and Rheumatology, UTHSCSA, San
Antonio, Texas
bDepartment of Molecular and Cellular Biochemistry, Osaka University Graduate School of
Dentistry, Suita, Osaka
Abstract
Fish oil has been used to alleviate pain associated with inflammatory conditions such as
rheumatoid arthritis. The anti-inflammatory property of fish oil is attributed to the n-3 fatty acids
docosahexaenoic acid and eicosapentaenoic acid. Contrarily, vegetable oils such as safflower oil
are rich in n-6 fatty acids which are considered to be mediators of inflammation. This study
investigates the effect of n-3 and n-6 fatty acids rich oils as dietary supplements on the thermally
induced pain sensitivity in healthy mice. C57Bl/6J mice were fed diet containing regular fish oil,
concentrated fish oil formulation (CFO) and safflower oil (SO) for 6 months. Pain sensitivity was
measured by plantar test and was correlated to the expression of acid sensing ion channels
(ASICs), transient receptor potential vanilloid 1 (TRPV1) and c-fos in dorsal root ganglion cells.
Significant delay in sensitivity to thermal nociception was observed in mice fed CFO compared to
mice fed SO (p<0.05). A significant diminution in expression of ion channels such as ASIC1a
(64%), ASIC13 (37%) and TRPV1 (56%) coupled with reduced expression of c-fos, a marker of
neuronal activation, was observed in the dorsal root ganglion cells of mice fed CFO compared to
that fed SO. In conclusion, we describe here the potential of fish oil supplement in reducing
sensitivity to thermal nociception in normal mice.
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1 Introduction
Pain is an important debilitating factor, especially during aging and under conditions of
existing pathologies. While aging does not automatically induce pain, it may alter a person’s
ability to respond to pain effectively. Chronic pain negatively affects the quality of life and
© 2011 Elsevier Ltd. All rights reserved.
*Address for correspondence: Gabriel Fernandes, Ph.D, Professor of Medicine, Physiology and Microbiology and Immunology,
Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Texas Health Science Center at San
Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, USA 78229, fernandes@uthscsa.edu, Phone: 1-210-567-4679, Fax:
1-210-567-4592.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Pharmacol Res. Author manuscript; available in PMC 2012 May 1.
Published in final edited form as:
Pharmacol Res. 2011 May ; 63(5): 377–382. doi:10.1016/j.phrs.2011.02.004.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
is one of the leading causes of depression. However, it is possible to manage pain,
physiological as well as pathological, by adopting a suitable nutritional strategy and/or by
using dietary supplements [1]. This approach is now being advocated as an alternative to
pain killer drugs. Nevertheless, with the existence of an ever expanding multi-billion dollar
market for anti-inflammatory pharmaceutical drugs, the benefits of dietary supplements
largely remain repressed.
Dietary fatty acids play an important role in determining the body’s inflammation status.
While n-6 fatty acids are known to be precursors of inflammatory mediators, n-3 fatty acids
are known to possess anti-inflammatory properties. We have earlier reported the beneficial
effects of n-3 fatty acids on inhibition of autoimmunity and osteoporosis in mice [2–4].
Apparently, it is the ratio of n-6 to n-3 fatty acids rather than the absolute quantity of fatty
acids that is critical to their health benefits [5]. A higher ratio of n-6/n-3 fatty acids mostly
favors inflammation. While the optimum ratio is thought to be 4:1, the current Western diet
is largely deficient in n-3 fatty acids with this ratio ranging from 10:1 to 20–25:1 [6,7].
Further, high level of arachidonic acid (AA), a precursor of 4-series leukotrienes (LT) and
the chief inflammatory metabolite of linoleic acid (n-6 fatty acid), is responsible for a
cascade of events leading to inflammation, pain and manifestation of several disorders [8–
10]. Arachidonic acid is also a precursor of inflammatory prostaglandins (PG) which
sensitize pain receptors on nerve endings through their action on ion channels [10,11].
Nutritional intervention may largely influence the modulation inflammation [12]. For
example, a diet low in arachidonic acid (n-6 fatty acid) has shown to reduce the clinical
signs of inflammation in rheumatoid arthritis patients and also to augment the benefits of
fish oil supplementation with an accompanying increase in eicosapentaenoic acid (EPA,
20:5 n-3) in erythrocyte lipids and consequent reduction in inflammatory eicosanoids [13].
Therefore a diet low in n-6 fatty acids and high in n-3 fatty acids is desirable for a healthy
living.
Omega-3 fatty acids (n-3 fatty acids) possess strong anti-inflammatory and analgesic
properties. DHA and EPA are precursors of potent anti-inflammatory lipid mediators such as
resolvins and protectins [14]. Fish oil, a rich source of n-3 fatty acids such as EPA and
docosahexaenoic acid (DHA, 22:6 n-3), is often used as dietary supplement by rheumatoid
arthritis patients to alleviate joint pain [15]. Several studies have also shown that an
increased intake of n-3 polyunsaturated fatty acids (PUFA) is associated with reduced pain
in rheumatoid arthritis [15], inflammatory bowel disease [16] and dysmenorrhea [17]. Rats
treated with n-3 fatty acids have shown to markedly increase threshold for thermal pain [5].
Recently, Shapiro [18] suggested that n-3 PUFA might relieve pain by their direct action on
neurones. High dose of fish oil has also shown to significantly reduce circulating pro-
inflammatory cytokines, physician’s evaluation of pain and other clinical parameters in
rheumatoid arthritis patients, post discontinuation of non-steroidal anti-inflammatory drugs
(NSAIDs) [19]. A recent study has suggested clinically significant reduction of neuropathic
pain in human subjects [20]. While most studies reporting the effect of n-3 fatty acids on
pain mainly refer to injury-induced neuropathic pain [21,22] or pathological pain [15,23],
very few studies are available on their effect on sensitivity to nociception in normal subjects
[5,24]. A most recent study demonstrated the effect of DHA against thermal and chemical
nociception in a mouse model, where the mice were administered different doses of DHA 30
minutes before the test measurements [25]. However, despite many reports on the analgesic
effects of n-3 fatty acids, the mechanisms through which they delay pain sensitivity are not
fully understood. One study demonstrated inhibition of transient receptor potential vanilloid
subfamily 1 (TRPV1) currents by EPA in vitro in Xenopus oocyte model and also a
reduction of capsaicin-induced pain behavior in mice [26]. Interestingly, the authors also
demonstrated the TRPV1 agonistic activity of DHA through direct activation of the ion
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channel. However, the antagonistic activity of EPA was not accompanied by data on
expression of TRPV1 in vivo [26].
Therefore, the present study was aimed at testing the differential effects of long term
consumption of concentrated n-3 fatty acids-rich fish oil (CFO), regular fish oil (FO) and
n-6 fatty acids-rich safflower oil (SO) on thermally induced pain sensitivity in healthy aging
mice and elucidating the mechanisms therein. Concentrated FO used in the study is a FDA
approved prescription drug and contains high concentrations of EPA (46.5%) and DHA
(37.5%) [27]. Regular FO contains 18% EPA and 12% DHA. We selected SO as a source of
n-6 fatty acids to emphasize the mechanism for increased nociception and compare against
the benefits of fish oil.
2 Materials and Methods
2.1 Oils
Concentrated fish oil was obtained from Glaxo SmithKline, (Waltham, MA) and safflower
oil was obtained from MP Biomedicals (Solon, Ohio).
2.2 Animals and diet
Eleven month-old female C57Bl/6J mice, weighing 24–25g, were purchased from Jackson
Laboratories (Bar Harbor, Maine 04609 USA) and provided water and standard chow
AIN93G (diet recommended by AIN for growth) ad libitum for one month. At twelve
months, weight matched animals were divided into three groups, each containing 20 mice.
Subsequently, the animals were housed in a standard controlled animal care facility in cages
(5 mice/cage) and group I was fed a diet containing 4% regular FO, group II was fed diet
containing 4% CFO and group III was fed diet containing 5% SO diet ad libitum for 6
months. The oil concentration in the fish oil diet was made up to 5% with SO. The animals
were maintained in a temperature controlled room (22–25°C, 45% humidity) on a 12:12-h
dark-light cycle. National Institutes of Health guidelines were strictly followed, and all the
studies were approved by the Institutional Laboratory Animal Care and Use Committee of
the University of Texas Health Science Center at San Antonio (San Antonio, TX). Body
weight was measured weekly. The diets were prepared using AIN-93G semi-purified
powdered ingredients (Table 1).
2.3 Paw withdrawal latency (Plantar test)
Paw withdrawal response to thermal stimuli of radiant heat was measured using a device
(Plantar test, 7370; Ugo Basile, Comerio, Italy) as described previously [28,29]. Briefly,
mice were acclimatized to an 8"×8" clear plexiglass box on a plexiglass floor for one hour
before testing. The plantar surface of the hind paw was exposed to an infrared radiant heat
source positioned under the plexiglass floor. The paw withdrawal latencies were measured
electronically three times per session, separated by a minimum interval of 5 min. Paw
withdrawals due to locomotion or weight shifting were not counted, and the trials were
repeated. Data are expressed as paw withdrawal latency in seconds.
2.4 Isolation of mouse L3–L5 DRG’s
After 6 months on the experimental diet, the mice were killed under anesthesia. Fresh mouse
L3–L5 dorsal root ganglions (DRGs) were isolated as described elsewhere [30]. In brief,
mice were laid in the prone position and the spinal cord and the segmental distribution of the
DRG was exposed by making an incision across the spine. Parallel cuts were then made
through the vertebrae adjacent to the spinal cord, and the overlying muscle and bone were
removed. The last thoracic ganglion (T13) and the ganglion with the greatest contribution to
the sciatic nerve (L4) were identified for orientation with respect to the whole mouse. The
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dorsal roots are very short at the cervical and upper thoracic levels, and the ganglia lie
closely apposed to the spinal cord. L3–L5 DRG’s were removed, and placed in cold saline
solution. DRG’s were then processed either for RT-PCR, hematoxylin/eosin or c-fos
immuno-staining.
2.5 Hematoxylin & Eosin staining of DRGs
DRGs at lumbar level L3–L5 were removed, fixed in 10% formalin for 24 h and processed
and embedded in paraffin. Serial sections (5 µm thick) were made using a sliding microtome
and standard hematoxylin and eosin (H&E) staining was performed for structural
verification of the sections.
2.6 Immuno-histochemistry of c-fos in mouse DRGs
Sections of DRGs were processed for c-fos immunohistochemistry according to Iwata et al
[31]. After removal, the DRGs were immersed in formalin fixative for 72 h. Tissues were
processed in the standard manner, embedded in paraffin and 5 µm sections were cut with a
microtome. Sections were incubated in 1.5% normal goat serum (NGS) and 0.1% bovine
serum albumin (BSA, Sigma, St. Louis, MO, USA) for 24 h at 4°C. Next, the sections were
incubated for 72 h in rabbit anti-c-fos (1:2000; Oncogene Science, Cambridge, MA, USA) at
4°C. Subsequently, the sections were incubated in biotinylated goat anti-rabbit (1:200;
Vector Labs, Burlingame, CA, USA) for 1 h at 37°C and peroxidase-conjugated avidin-
biotin complex (1:100; ABC, Vector Labs) for 4 h at 25°C. To develop the ABC reaction
product, the sections were incubated in 0.035% 3,3′-diaminobenzidine-tetra HCl (DAB;
Sigma) and 0.05% peroxide in 0.05 M Tris-buffer (TB, pH 7.4), resulting in a distinctive
deposit of brown granules on the nuclei of cells. Between each incubation, sections were
rinsed three times by 0.01 M PBS for 15 min. Every other section was counterstained with
hematoxylin.
2.7 Reverse transcriptase-polymerase chain reaction (RT-PCR)
Fresh mouse dorsal root ganglions (DRGs) (L3–L5) were dissected following the protocol
as described earlier. Total RNA was isolated using RNAeasy Mini-kit (Qiagen, Valencia,
CA). Single-strand cDNA was synthesized from 0.4µg RNA using Superscript III first-
strand kit (Invitrogen, Carlsbad, CA). The expression levels of ASIC1a, ASCI3 and TRPV1
were assessed with 10ng total RNA using Taqman Gene Expression Assays (Applied
Biosystems) in an Applied Biosystems 7900HT Sequence Detection System according to
manufacturer’s instructions. Appropriate negative controls (no-template control) were also
run in each reaction. Relative quantification was obtained using 2−ΔΔCt after normalization
of the Ct data to that of the housekeeping gene, GAPDH, where Ct is the threshold cycle of
fluorescence detection.
3 Statistical analysis
Data are presented as mean values ± SEM. Students’ t-test was used to evaluate differences
between samples of fish oil diet group with the corresponding SO diet group as the control
samples. p≤0.05 was considered statistically significant. The analyses were performed using
GraphPad prism for Windows (La Jolla, CA, USA).
4 Results
4.1 Effect of FO and SO on response time to thermal nociception
Response to thermal hyperalgesia was measured by exposing the plantar region of paw of
mice (n=6) to a source of radiant heat. An increase in withdrawal response time was
observed in C57Bl/6J mice fed CFO (13.52±1.3 sec) and FO (11.04±0.61 sec) enriched diet
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compared to that in mice fed SO rich diet, which showed paw withdrawal response at
9.28±0.62 sec. Resistance to thermal nociception was significantly higher in CFO fed mice
(p<0.05) compared to SO fed mice while it was not statistically significant in regular FO fed
mice suggesting a significant reduction in sensitivity to heat induced pain in mice
supplemented with CFO (Fig. 1A). The test was also carried out on BW mice fed
experimental diets for six months and the results showed significantly reduced sensitivity in
CFO fed mice (Fig. 1B).
Since mice fed regular FO did not show significant increase in resistance to thermally
induced nociception compared to SO fed mice, this group was excluded from further
analysis.
4.2 Effect on c-fos protein immunoreactivity in DRG
Immunohistochemical staining of DRGs, isolated from mice fed CFO and SO diets, using c-
fos antibody revealed dark brown granular structures representing c-fos protein (Fig. 2B).
The relative area of immunoreactivity was significantly lower in DRGs isolated from CFO
fed mice (5.12±0.31µm2) as compared to that from SO fed mice (7.23 ± 0.63µm2) at p<0.05
(Fig. 2C).Effect on pain sensing genes in DRG: To evaluate the molecular changes involved
in thermal nociception, we determined the mRNA expression of acid sensing ion channels,
ASIC1a, and ASIC3 as well as the cation channel, TRPV1 in DRGs of mice fed CFO and
SO enriched diets. The DRGs from L3–L5 were used for mRNA isolation since the sensory
nerves originating from this region innervate the limbs. Expression of pain genes was
normalized to the housekeeping gene, GAPDH. Reduction in the relative expression level of
mRNAs of ASIC1a, ASIC13 (p<0.05) and TRPV1 (p<0.001) was significant and was
recorded to be 64%, 37% and 56% respectively in DRGs of CFO fed mice compared to that
of SO fed mice.
5 Discussion
Pain is a consequence of an inflammatory status of the body. One of the factors that govern
inflammation is the balance between dietary n-6 and n-3 fatty acids which act as precursors
of inflammatory and anti-inflammatory lipid mediators respectively, through the action of
the enzymes cycloxygenase (COX) and lipoxygenase (LOX). It is believed that a high
concentration of n-6 fatty acids in the diet promotes inflammation due to increased
arachidonic acid (AA) level which is the chief precursor of inflammatory mediators such as
2 series prostaglandins (PGs) and 4 series leukotrienes (LTs). PGs and LTs increase vascular
permeability and sensitize pain receptors [32,33] leading to increased sensitivity to pain.
However, when a diet predominantly contains n-3 fatty acids such as EPA and DHA, these
fatty acids compete with AA as substrates for COX and LOX to form anti-inflammatory,
PGE3 and LT5 [34,35]. We have shown, in the present study, that mice fed a CFO
supplemented diet exhibited a modest but statistically significant reduction in sensitivity to
thermal nociception as compared to mice on SO supplemented diet. It appears that the high
concentration of n-3 fatty acids, EPA and DHA in CFO is largely responsible for reduced
pain sensitivity since no significant effect was observed in mice fed regular FO.
To understand the mechanisms involved, we studied the changes in the expression of c-fos
protein and pain sensing genes. C-fos, an immediate early gene, is a powerful marker of
neuronal activation and though not specific, is considered a neural marker of pain [36].
Immunoreactivity of c-fos was significantly higher in DRG of SO supplemented mice
compared to CFO fed mice. Apparently, AA and its metabolites (PGs) stimulate the mRNA
expression of c-fos and blocking the PG production through COX inhibition abolishes the
expression of AA induced mRNA [37] as well as protein expression of c-fos [38].
Stimulatory effect of AA is believed to be mediated via synthesis of PGE2 and subsequent
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activation of protein kinase C possibly through PGE2 receptor coupled to phospholipase C.
However, this stimulatory effect was not reproduced with structurally similar compounds
[37] suggesting the specificity of AA as a stimulus for c-fos induction. Additionally, the
elevated levels of pro-inflammatory cytokines like IL-6 may also have a stimulatory effect
on c-fos activation [39]. We have earlier shown that high levels of endogenous n-3 fatty
acids reduce circulating inflammatory cytokines such as TNFα and IL-6 in Fat-1 mice [40].
Yoneda et al [29] have earlier reported that hyperalgesia is associated with an increase in c-
fos immunoreactivity accompanied by activation of ASICs. Therefore, the increased c-fos
expression in SO fed mice may be indicative of amplified neuronal activation and
consequent increased sensitivity to thermal nociception.
Furthermore, acid-sensing ion channels, such as ASIC1a, ASIC1b and ASIC3 and transient
receptor potential vanilloid 1 (TRPV1), are implicated in pain perception [41]. Activation of
these ion channels is a complex mechanism and involves one or more factors such as proton
sensitive ion channels, the ASICs and transient receptor potential cation channels being the
most important ones involved in pain perception [41]. Acid sensing ion channels which are
present on the nociceptive sensory neurones are activated by proton-gated depolarizing
currents [42]. Arachidonic acid is known to produce high proton concentrations (acidosis)
under physiological as well as pathological conditions [43,44] and tissue acidosis is believed
to be yet another cause of inflammation and pain [45]. ASIC3 is most sensitive to changes in
tissue acidity [46]. In the present study expression of both ASIC1a and ASIC3 were
significantly reduced by fish oil diet compared with SO fed mice. TRPV1 was also
significantly affected by the diets and it is believed to play a central role in proton detection
[47] and hence pain perception. It is also suggested that inflammatory acidic environments
activate TRPV1 leading to series of events involved in inflammatory pain [48]. Given the
overall increase in inflammatory markers in SO fed mice, we presume that there may be an
increased intracellular or extracellular protons concentration which may result in activation
of a variety of ion channels involved in pain perception [49]. However, in the absence of
concrete data on the tissue pH, these claims are only presumptive and warrant further studies
to correlate pain with tissue pH, ion channel activation and cytokine production.
Further, oxidized linoleic acid metabolites such as 9- and 13-hydroxyoctadecadienoic acid
(9-HODE/13-HODE) are found to activate TRPV1 in the spinal cord contributing to
hyperalgesia [50]. TRPV1 is shown to selectively mediate thermal nociception [51]. We
observed, for the very first time, that mRNA expression of ASIC1a, ASIC3 and TRPV1 was
significantly lower in CFO fed mice, when compared to SO fed mice, suggesting a reduced
inflammatory status which may be the reason for increased pain threshold in the former
group. It is known that fish oil, which contains n-3 fatty acids, possesses analgesic property
and is used in various inflammatory disorders to alleviate pain [17,19,23,52]. Further, since
SO is chiefly composed of linoleic acid, it may be possible that it is metabolized to 9- and
13-hydroxy-octadecadienoic acids (HODEs) [53,54] apart from AA and reduce the pain
threshold in mice fed SO supplemented diet. Since formation of HODEs is inhibited by
COX and LOX inhibitors [53,55], supplementing n-3 fatty acids may preferentially utilize
these enzymes for the production of less potent PGE3 and LTB5. The analgesic property of
n-3 fatty acids is also attributed to their ability to generate resolvins and protectins in vivo.
For example, DHA and EPA, act as precursors of D series (RvD1, RvD2) and E-series
(RvE1, RvE2) of resolvins respectively, which exhibit potent anti-inflammatory properties
[56]. A recent study has shown resolvins to normalize synaptic plasticity in spinal cord
dorsal horn neurons thus reducing hypersensitivity to inflammatory pain [57].
The use of fish oil has been suggested to be useful in reducing the dose of NSAIDs for
chronic inflammatory disorders [58,59] and as safer alternatives to NSAIDs [52]. NSAIDs
mainly act through inhibition of COX. Since fish oil fatty acids require COX to form the
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anti-inflammatory PGs and LTs, theoretically, analgesic effects resulting from its co-
administration with NSAID should be attributed to the latter alone. From this it appears that
fish oil fatty acids may not be solely dependent on eicosanoid production for its analgesic
effect but may act independently through mechanisms involving cytokines, pain sensing ion
channels and other transcriptional factors.
6 Conclusion
This work contributes to the mechanistic overview for justifying the already existing data on
anti-inflammatory and antihyperalgesic effects of n-3 fatty acids. Furthermore, the new
information that it does so by partly acting through acid sensing ion channels and neuronal
activators, adds to better understanding of its mechanisms. Further studies on the effect of
fish oil on other nociceptive modalities like chemical and mechanical nociception are
warranted to confirm this data on thermal nociception.
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Figure 1.
Plantar assay of (A) C57Bl/6J mice and (B) BW mice after 6 months on diets. Data
represent mean ± SEM (n=6). CFO significantly delayed the pain sensitivity in both the
strains of mice compared to SO fed mice at a level of significance p<0.05 by Student’s t-
test.
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Figure 2.
c-fos immuno-staining of the DRGs isolated from mice fed CFO and SO. L3–L5 Dorsal root
ganglion was isolated from mice fed CFO and SO and processed for, A) H&E staining for
structural verification (original magnification, 20×). B) Section of a DRG was immuno-
stained with rabbit anti-human c-fos antibody (original magnification, 40×). Development
was carried out using the appropriate Vector Stain kit (Vector Labs, Burlingame, CA), and
counterstained with hematoxylin. Photomicrographs were recorded using a light microscope.
Brown staining represents the presence and intensity of c-fos. C) Quantitation of relative c-
fos immuno-reactive area in DRG of mice fed diets (mean±SE, n=6). Relative c-fos
immuno-reactive area was found to be significantly lower (p<0.05 by Student’s t-test) in
DRG of CFO fed mice indicating reduced expression of c-fos.
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Figure 3.
Quantitative RT-PCR analysis of ASIC1a, ASIC3 and TRPV1 in dorsal root ganglion of
C57Bl/6J mice (n=6) fed CFO and SO enriched diets. DRGs were isolated from L3–L5
region of mice fed experimental diets and processed for RNA isolation. Relative
quantification of mRNA was expressed as fold change with respect to SO diet using 2−ΔΔCt
after normalization of the Ct data to that of the housekeeping gene, GAPDH. Data represent
the mean ± S.E.M. A significant reduction in the expression of ASIC1a, ASIC3 and TRPV1
was observed in DRGs of mice fed CFO compared to that in SO fed mice. *p<0.05;
**p<0.001 vs SO fed mice, according to Unpaired Student’s t-test.
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Table 1
Composition of AIN-93G diet containing oils.
Ingredients (g) 4% FO 5% SO
Casein 140.0 140.0
L-lysine 1.8 1.8
Corn starch 424.3 424.3
Dextrinized corn starch 195 195
Sucrose 90 90
FO 40.0 00.0
Safflower oil 10.0 50.0
Cellulose 50.0 50.0
AIN-93 mineral mix 35.0 35.0
Choline bitartarate 2.5 2.5
AIN-93 vitamin mix 10.0 10.0
TBHQ 1.0 1.0
Vitamin E 0.4 0.4
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